scholarly article | Q13442814 |
P356 | DOI | 10.1093/RHEUMATOLOGY/KEU273 |
P8608 | Fatcat ID | release_zvk3dkguprbu3a7jqghx4naxq4 |
P698 | PubMed publication ID | 25065010 |
P5875 | ResearchGate publication ID | 264290578 |
P50 | author | James M Brewer | Q37385291 |
Iain McInnes | Q41687181 | ||
Robert A Benson | Q58382147 | ||
P2093 | author name string | Paul Garside | |
Martin Braddock | |||
Andrew M Platt | |||
John P Butcher | |||
Ross McQueenie | |||
P2860 | cites work | Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 |
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases | Q28237805 | ||
An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis | Q28294375 | ||
ICOS is essential for effective T-helper-cell responses | Q28594859 | ||
Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation | Q29614224 | ||
The pathogenesis of rheumatoid arthritis | Q29614957 | ||
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
Intra-articular and circulating immune complexes and antiglobulins (IgG and IgM) in rheumatoid arthritis; correlation with clinical features | Q33551716 | ||
Therapeutic targeting of Syk in autoimmune diabetes | Q34308759 | ||
The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo | Q34440540 | ||
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation | Q34562439 | ||
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis | Q34896320 | ||
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk | Q35125868 | ||
Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor | Q35195563 | ||
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis | Q35821357 | ||
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization | Q36367948 | ||
Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles | Q36512352 | ||
The SYK tyrosine kinase: a crucial player in diverse biological functions | Q36662082 | ||
Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation | Q37101076 | ||
Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness | Q37144550 | ||
Evidence that cytokines play a role in rheumatoid arthritis | Q37316594 | ||
T cells in rheumatoid arthritis | Q37324840 | ||
Common variants at CD40 and other loci confer risk of rheumatoid arthritis | Q37376871 | ||
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. | Q42767257 | ||
Identifying the cells breaching self-tolerance in autoimmunity | Q43978140 | ||
A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. | Q44272104 | ||
A novel Syk kinase-selective inhibitor blocks antigen presentation of immune complexes in dendritic cells | Q45157810 | ||
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial | Q46271720 | ||
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus | Q46625173 | ||
Characterization of CD4+ T-cell-dendritic cell interactions during secondary antigen exposure in tolerance and priming. | Q51888898 | ||
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice. | Q54579373 | ||
In Vivo Generated Th1 Cells Can Migrate to B Cell Follicles to Support B Cell Responses | Q58867363 | ||
P433 | issue | 1 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 169-177 | |
P577 | publication date | 2014-07-26 | |
P1433 | published in | Rheumatology | Q7320492 |
P1476 | title | The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cells. | |
P478 | volume | 54 |
Q54144290 | Fostamatinib for persistent/chronic adult immune thrombocytopenia. |
Q36087431 | Kinases: a remote control in inflammasome activity |
Q48120395 | The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients. |
Search more.